TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study.

Uwe Platzbecker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.